ESC Professional Premium Access

The efficacy and safety of novel oral anticoagulants versus vitamin k antagonist in transcatheter aortic valve replacement patients with indications for anticoagulation

Congress Presentation

About the speaker

Doctor Jed Mclee Abella

Perpetual Succour Hospital, Cebu (Philippines)
0 follower

6 more presentations in this session

Risk of thromboembolic and bleeding events in patients with atrial fibrillation after valvular intervention in either aortic or mitral position

Speaker: Doctor E. Skogseid (Uppsala, SE)

Thumbnail

Safety and efficacy of protamine administration for prevention of bleeding complications in patients with recent PCI undergoing TAVR

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Thumbnail

Clinical outcomes in patients receiving oral anticoagulation stratified by the presence of dose reduction criteria and older age: a subanalysis of ENVISAGE-TAVI AF

Speaker: Professor N. van Mieghem (Rotterdam, NL)

Thumbnail

Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)

Speaker: Doctor C. Hohmann (Cologne, DE)

Thumbnail

Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr J. Lehto (Turku, FI)

Thumbnail

Access the full session

Walking the line between bleeding and thrombosis in valvular heart disease

Speakers: Doctor J. Abella, Doctor E. Skogseid, Doctor B. Al-Kassou, Professor N. van Mieghem, Doctor C. Hohmann...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations